<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garsi JB</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><pagination>949-954</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9190036</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(6)</volume><pubmed_abstract>On the basis of the knowledge that the proline-rich hot spot &lt;b>PPP&lt;/b>RPP region of P(151)PSNPPPRPP(160), an oligopeptide derived from the cytosolic portion of p22&lt;sup>phox&lt;/sup> (p22), binds to the single functional bis-SH3 domain of the regulatory protein p47&lt;sup>phox&lt;/sup> (p47), we designed a mimetic of the tripeptide &lt;b>PPP&lt;/b> based on NMR and X-ray crystallographic data for the p22(151-161) peptide PPSN&lt;b>PPP&lt;/b>RPPA with a peptide construct. Incorporation of the synthetic pseudo-triproline mimetic Pro-Pro-Cyp in a molecule derived from molecular modeling studies led to only a 7-fold diminution in activity in a surface plasmon resonance assay relative to the same molecule containing the natural Pro-Pro-Pro tripeptide. The alternative sequence corresponding to a Pro-Cyp-Pro insertion was inactive. This is a first example of the use of a triproline mimetic to interfere with the formation of the p47-p22 complex, which is critical for the activation of NOX, leading to the production of reactive oxygen species as superoxide anions.</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pubmed_title>Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.</pubmed_title><pmcid>PMC9190036</pmcid><funding_grant_id>IRCPJ 531309 - 17</funding_grant_id><pubmed_authors>Szlavik Z</pubmed_authors><pubmed_authors>Lancelot N</pubmed_authors><pubmed_authors>Cullia G</pubmed_authors><pubmed_authors>Fordos E</pubmed_authors><pubmed_authors>Sipos Z</pubmed_authors><pubmed_authors>Vuillard LM</pubmed_authors><pubmed_authors>Balazs B</pubmed_authors><pubmed_authors>Brown D</pubmed_authors><pubmed_authors>Fejes I</pubmed_authors><pubmed_authors>Markacz P</pubmed_authors><pubmed_authors>Komjati B</pubmed_authors><pubmed_authors>Cukier C</pubmed_authors><pubmed_authors>Garsi JB</pubmed_authors><pubmed_authors>Raimbaud E</pubmed_authors><pubmed_authors>Hanessian S</pubmed_authors><pubmed_authors>Sipos M</pubmed_authors><pubmed_authors>Berger S</pubmed_authors><pubmed_authors>Haberkorn L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.</name><description>On the basis of the knowledge that the proline-rich hot spot &lt;b>PPP&lt;/b>RPP region of P(151)PSNPPPRPP(160), an oligopeptide derived from the cytosolic portion of p22&lt;sup>phox&lt;/sup> (p22), binds to the single functional bis-SH3 domain of the regulatory protein p47&lt;sup>phox&lt;/sup> (p47), we designed a mimetic of the tripeptide &lt;b>PPP&lt;/b> based on NMR and X-ray crystallographic data for the p22(151-161) peptide PPSN&lt;b>PPP&lt;/b>RPPA with a peptide construct. Incorporation of the synthetic pseudo-triproline mimetic Pro-Pro-Cyp in a molecule derived from molecular modeling studies led to only a 7-fold diminution in activity in a surface plasmon resonance assay relative to the same molecule containing the natural Pro-Pro-Pro tripeptide. The alternative sequence corresponding to a Pro-Cyp-Pro insertion was inactive. This is a first example of the use of a triproline mimetic to interfere with the formation of the p47-p22 complex, which is critical for the activation of NOX, leading to the production of reactive oxygen species as superoxide anions.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-27T02:21:11.418Z</modification><creation>2025-04-06T18:32:36.752Z</creation></dates><accession>S-EPMC9190036</accession><cross_references><pubmed>35707140</pubmed><doi>10.1021/acsmedchemlett.2c00094</doi></cross_references></HashMap>